TolerogenixX GmbH

📍 Heidelberg, Germany🗓 Founded 2016👥 3 employees💰 Last funded 2016
Biotechnology Research🌐 tolerogenixx.com
Website LinkedIn
TolerogenixX vision is to innovate Immunosuppression with its newly developed MIC Cell Treatments. MIC Cell Treatment is a curative ATMP approach to achieve a sustained regulation of the immune system in Transplant - and Autoimmune Disease Patients. TolerogenixX has been able to generate strong pre-clinical as well as clinical data in the indications of Transplantation and Autoimmune Diseases e.g. SLE since its foundation in 2016.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in TolerogenixX GmbH?
TolerogenixX GmbH has 1 investors on record on gritt.io, including 1 early-stage backers.
When did TolerogenixX GmbH last raise funding?
The most recent investment in TolerogenixX GmbH recorded on gritt.io was in 2016.
When was TolerogenixX GmbH founded?
TolerogenixX GmbH was founded in 2016.
What industry is TolerogenixX GmbH in?
TolerogenixX GmbH operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is TolerogenixX GmbH based?
TolerogenixX GmbH is headquartered in Heidelberg, Germany.